High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effect
Huawei Tong, Jia Huang, Qingquan Xiao, Bingbing He, Xue Dong, Yuanhua Liu, Xiali Yang, Dingyi Han, Zikang Wang, Xuchen Wang, Wenqin Ying, Runze Zhang, Wei Yu, Chunlong Xu, Yingsi Zhou, , Hui Yang
The paper designs high-fidelity Cas13 variants with minimal collateral RNA degradation effects, validated in mammalian cells and transgenic mice.
Nature Biotechnology · Aug 11, 2022Peer-reviewedMolecular Biology